Nyxoah’s hypoglossal nerve stimulation system, Genio, met the co-primary endpoints at 12 months in the pivotal DREAM trial in ...

The persistent hypoglossal artery (PHA) is a rare vascular anomaly that can have significant implications for patients, particularly in relation to carotid artery diseases and cerebrovascular ...